Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Subjects:

Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ_<i>S</i> paramete... by Keith Fraser (1868587)

Subjects:

Fig 6 - by Keith Fraser (1868587)

Subjects:

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

Subjects:

Table of parameters. by Keith Fraser (1868587)

Subjects:

Fig 7 - by Keith Fraser (1868587)

Subjects:

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

Preparatory neuronal activity in ALM is decreased, but remains significant in quiet trials devoid of movements. by Vahid Esmaeili (12700352)

Mixed effects cox regression showing predictors of viral suppression using hazard ratios among persons with post-ART viral load tests in Jamaica, 2017–2019. by Anya Cushnie (11269155)

Subjects:

Kaplan-Meier curve for time to viral suppression stratified by type of treatment site (public versus NGOs). by Anya Cushnie (11269155)

Subjects:

Cumulative probability of viral suppression by ART year of initiation. by Anya Cushnie (11269155)

Subjects:

Cumulative probability of viral suppression by treatment site. by Anya Cushnie (11269155)

Subjects:

Median time to viral suppression among persons with post-ART viral load tests in Jamaica by ARV initiation year, sex and treatment site, 2017–2019 (N = 2049). by Anya Cushnie (11269155)

Subjects:

Characteristics of PLHIV in Jamaica who initiated ARV treatment between 2017–2019 with pre and post ART viral load tests (N = 4560). by Anya Cushnie (11269155)

Subjects:

Kaplan-Meier curve for time to viral suppression stratified by year of ARV initiation. by Anya Cushnie (11269155)

Subjects:

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Image1_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…Up until the COVID-19 pandemic, lung cancer incidence was decreasing by 3.18% (2.1%–4.3%) yearly in men, while there was no significant decrease in women. …”

Image2_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…Up until the COVID-19 pandemic, lung cancer incidence was decreasing by 3.18% (2.1%–4.3%) yearly in men, while there was no significant decrease in women. …”

Image3_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…Up until the COVID-19 pandemic, lung cancer incidence was decreasing by 3.18% (2.1%–4.3%) yearly in men, while there was no significant decrease in women. …”

Image4_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…Up until the COVID-19 pandemic, lung cancer incidence was decreasing by 3.18% (2.1%–4.3%) yearly in men, while there was no significant decrease in women. …”